It has been ascertained that one of several possible reasons for negligible interferon activity in solid tumors, namely, hepatic metastases induced in rats after intraportal injection of Walker carcinoma 256 cells, is the significantly lower levels of interferon in the interstitial fluid of metastases in comparison to normal liver and plasma.

Bocci, V., Carraro, F., Naldini, A., Cagol, P.P., Pasqual, E.M., Prevaldi, C., et al. (1990). Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases. MOLECULAR BIOTHERAPY, 2(4), 233-234.

Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases

BOCCI, V.;CARRARO, F.;NALDINI, A.;
1990-01-01

Abstract

It has been ascertained that one of several possible reasons for negligible interferon activity in solid tumors, namely, hepatic metastases induced in rats after intraportal injection of Walker carcinoma 256 cells, is the significantly lower levels of interferon in the interstitial fluid of metastases in comparison to normal liver and plasma.
1990
Bocci, V., Carraro, F., Naldini, A., Cagol, P.P., Pasqual, E.M., Prevaldi, C., et al. (1990). Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases. MOLECULAR BIOTHERAPY, 2(4), 233-234.
File in questo prodotto:
File Dimensione Formato  
Distribution of human recombinant interferon-a2 in rat plasma, liver, and experimental liver metastases1990.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 960.12 kB
Formato Adobe PDF
960.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/8178
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo